OpenPV Signal Explorer
FAERS disproportionality dashboard
Reaction

Pulmonary Nocardiosis reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 807 reports · 36 co-occurring drugs

As of the last recalculation, Pulmonary Nocardiosis appears in 807 FAERS reports alongside 36 co-occurring drug terms. The strongest observed disproportionality signal is VALGANCICLOVIR HYDROCHLORIDE POWDER, (PRR 192.9).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Valganciclovir Hydrochloride Powder,82192.9194.2
Tacrolimus Ointment 0.1%418178.5179.1
Tacrolimus Extended-Release Capsules418178.0178.6
Atovaquone46156.2157.1
Tacrolimus429149.7150.1
Mycophenilic Acid102145.2145.9
Valganciclovir85129.9130.4
Valganciclovir Hydrochloride85129.9130.4
Mycophenolic Acid10395.095.3
Basiliximab3682.682.8
Mycophenolate Mofetil25469.970.1
Mycophenolate Mofetil Hydrochloride25469.869.9
Alemtuzumab4665.065.1
Prednisolone22443.944.0
Prednisolone Oral22443.944.0
Prednisolone Oral Solution22443.944.0
Methylprednisolone17942.642.7
Anti-Thymocyte Globulin (Rabbit)1342.242.3
Posaconazole Delayed-Release1638.338.4
Remdesivir1529.629.6
Piperacillin And Tazobactam1428.728.7
Meropenem3327.627.6
Ceftriaxone3226.226.2
Posaconazole1625.925.9
Itraconazole1124.624.6
Linezolid2724.224.2
Sirolimus1223.323.3
Ceftriaxone Sodium3323.123.1
Voriconazole Injection1720.620.6
Piperacillin Sodium,Tazobactam Sodium1918.918.9
Piperacillin Sodium And Tazobactam Sodium1418.718.7
Minocycline817.917.9
Voriconazole1714.714.7
Amikacin913.713.8
Selinexor39.09.0
Azacitidine For68.68.6

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.